| Impact of harm reduction practice on the use of non-prescribed performance-and image-enhancing drugs: The PUSH! Audit B Eu, J Dawe, M Dunn, K Lee, S Griffiths, M Bloch, D Baker, CTM Soo, ... Australian Journal of General Practice 52 (4), 197-202, 2023 | 5 | 2023 |
| Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020 J Dawe, AL Wilkinson, J Asselin, A Carter, A Pedrana, MW Traeger, ... International Journal of Drug Policy 104, 103696, 2022 | 5 | 2022 |
| Prompt-point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities L Ralton, EM McCartney, C Ferguson, J Dawe, J Richmond, E Tse, ... Proceedings of the International Conference on Hepatitis Care in Substance Users, 2021 | 5 | 2021 |
| Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study. B Eu, J Dawe, M Dunn, K Lee, N Roth, S Griffiths, M Bloch, D Baker, ... HIV medicine 24 (2), 2023 | 2 | 2023 |
| Point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities–the PROMPt Study EM McCartney, L Ralton, J Dawe, J Richmond, J Zobel, A Wigg, V Cock, ... Clinical Infectious Diseases, ciae155, 2024 | 1 | 2024 |
| Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a … R Sacks-Davis, DK van Santen, A Boyd, J Young, A Stewart, JS Doyle, ... The Lancet HIV 11 (2), e106-e116, 2024 | 1 | 2024 |
| Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing J Dawe, D Cassano, R Keane, S Ruth, AL Wilkinson, I Elsum, J Gunn, ... HIV medicine 24 (12), 1253-1267, 2023 | 1 | 2023 |
| Evaluation of a Project Integrating Financial Incentives into a Hepatitis C Testing and Treatment Model of Care at a Sexual Health Service in Cairns, Australia, 2020–2021 J Dawe, C Gorton, R Lewis, JA Richmond, AL Wilkinson, A Pedrana, ... Viruses 16 (5), 800, 2024 | | 2024 |
| Interpreter requirements of women from non-English speaking migrant backgrounds in maternity hospitals in Melbourne, Australia J Dawe, E McDonald, E Riggs, J Szwarc, J Yelland International Journal of Migration, Health and Social Care 19 (3/4), 299-309, 2023 | | 2023 |
| Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the Tasmanian Eliminate … J Dawe, M Hughes, S Christensen, L Walsh, JA Richmond, A Pedrana, ... BMC Public Health 23 (1), 2289, 2023 | | 2023 |
| Alisa Pedrana1, 4, Anna L. Wilkinson1, 4, 5, Louise Owen2, Joseph S. Doyle1, 6 and on behalf of the EC Australia Partnership J Dawe, M Hughes, S Christensen, L Walsh, JA Richmond | | 2023 |
| Monitoring and reporting of adverse effects of testosterone prescribing for gender affirmation at general practice clinics - Data from the PUSH! Audit MS B Eu, J Dawe, M Dunn, J Grace, K Lee, S Griffiths, M Bloch, D Baker, C ... International Journal of Transgender Health, 2023 | | 2023 |
| What are the reported adverse effects of performance and image enhancing drugs use?-Data from the PUSH! Study B Eu, M Dunn, J Dawe, K Lee, S Griffiths, M Bloch, D Baker, F Bisshop, ... Deakin University, 2022 | | 2022 |
| Point of care testing for hepatitis C in the priority settings of mental health, prisons and drug and alcohol facilities C Ferguson, L Ralton, E McCartney, J Dawe, J Richmond, E Tse, A Wigg, ... Journal of Hepatology 77, S228, 2022 | | 2022 |
| THE WHO, WHAT, WHY OF PERFORMANCE AND IMAGE ENHANCING DRUGS USE AND THE ADVERSE EFFECTS REPORTED-DATA FROM THE PUSH AUDIT B Eu, K Lee, M Dunn, S Griffiths, D Baker, M Bloch, C Soo, F Bisshop, ... Deakin University, 2021 | | 2021 |
| EFFECTS OF ANXIETY AND DEPRESSION ON ADVERSE HEALTH OUTCOMES AND HARM MANAGEMENT APPROACHES AMONG PEOPLE WHO USE NON-PRESCRIBED PERFORMANCE AND IMAGE ENHANCING DRUGS-DATA FROM … B Eu, K Lee, M Dunn, S Griffiths, D Baker, M Bloch, C Soo, F Bisshop, ... Deakin University, 2021 | | 2021 |
| SYMPOSIUM: THE PUSH (PIEDS USERS'HEALTH) AUDIT-DATA COLLECTED FROM GENERAL PRACTITIONER CLINICS ACROSS AUSTRALIA-WHO ARE THEY, WHAT ARE THE ADVERSE EFFECTS THEY EXPERIENCE AND … B Eu, K Lee, M Dunn, S Griffiths, D Baker, M Bloch, C Soo, F Bisshop, ... Deakin University, 2021 | | 2021 |
| THE MEASURED ADVERSE EFFECTS OF PERFORMANCE AND IMAGE ENHANCING DRUGS USE-WHAT IS REAL AND WHAT IS OVER-STATED? MEASURED ADVERSE EFFECTS DATA FROM THE PUSH AUDIT B Eu, K Lee, M Dunn, S Griffiths, D Baker, M Bloch, C Soo, F Bisshop, ... Deakin University, 2021 | | 2021 |
| THE PUSH AUDIT-DESIGN, RECRUITMENT AND THE ROLE OF GENERAL PRACTITIONERS IN HARM REDUCTION IN THE NON-PRESCRIBED PERFORMANCE AND IMAGE ENHANCING DRUGS USE POPULATION B Eu, K Lee, M Dunn, S Griffiths, D Baker, M Bloch, C Soo, F Bisshop, ... Deakin University, 2021 | | 2021 |
